Device / Technology News

RSS

Saladax, Bristol-Myers Squibb expand Alzheimer's diagnostic assays agreement

Bristol-Myers Squibb Company and Saladax Biomedical, Inc., announced today they have expanded their multi-year agreement covering the development and commercialization of diagnostic assays for the early detection of Alzheimer's disease to include Ortho-Clinical Diagnostics, Inc.

21 Sep 2011

Two IGB faculty members recognized as University Scholars

Paul Kenis and James Slauch have been named as University Scholars, a program created to recognize the university's most talented teachers, scholars and researchers.

21 Sep 2011

IRIDEX licenses rights to Ocunetics' intellectual property

IRIDEX Corporation today announced that it has exclusively licensed the rights to all of the intellectual property of Ocunetics, Inc., a privately held company based in Alamo, California. Ocunetics develops procedure-enabling medical devices that are intended to increase surgeons' efficiency, while improving case predictability for ophthalmic surgeries.

21 Sep 2011

Influential leaders hold high-level discussions on biomedical S&T initiatives

Influential leaders from the medical and research communities held high-level discussions on biomedical science and technology (S&T) initiatives at the Office of Naval Research (ONR), Sept. 16.

21 Sep 2011

GI Dynamics introduces EndoBarrier Gastrointestinal Liner in Austria

GI Dynamics, Inc. today announced the launch of the EndoBarrier Gastrointestinal Liner in Austria, the establishment of the first two Centers of Excellence and the treatment of patients at each new Center.

21 Sep 2011

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that in a rodent contusion model of SCI the Company's proprietary biopolymer scaffold showed positive preliminary data that indicate a therapeutic effect.

21 Sep 2011

MRI screenings for breast cancer benefit high-risk, underserved women

Using breast magnetic resonance imaging (MRI) screenings among targeted, high-risk, underserved women significantly decreased diagnostic cost and increased patient compliance rates with follow-up compared to using general risk mammography screenings.

21 Sep 2011

FDA clears Toshiba's advanced M-Power interface

Increasing MR exam efficiency, Toshiba America Medical Systems, Inc.'s advanced M-Power interface has received FDA clearance. M-Power is a customizable MR system user interface enabling technologists to streamline and accelerate scanning processes and enhance diagnoses.

21 Sep 2011

NUI Galway researchers develop super-sized model of heart valve

Researchers at NUI Galway have developed a super-sized model of a heart valve which may lead to a new generation of cardiovsacular devices.

21 Sep 2011

Clinical trial to evaluate TAU's stem cell technology for ALS

The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

21 Sep 2011

Aetna supports mHealth diabetes initiative in India

Aetna, a leading global diversified health care benefits company, announced that it is participating in a diabetes prevention program in India led by non-profit Arogya World that strives to reach one million consumers via mobile text messages.

21 Sep 2011

Enrollment complete in STENTYS Self-Apposing Stent clinical study for treatment of AMI

STENTYS S.A., a medical technology company that is commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the 500-patient target of the international APPOSITION III study for its Self-Apposing Stent.

21 Sep 2011

Smith & Nephew's TRUCLEAR System to improve training for gynecologists

Smith & Nephew plc, the global medical technology business, today announced the introduction of its TRUCLEAR SIM Morcellation Simulator, a highly-realistic, hands-on simulator designed to improve training for gynecologists who perform hysteroscopic morcellation, a procedure to remove intrauterine polyps and fibroids.

21 Sep 2011

New blood test can help detect heart attacks

Loyola University Chicago Stritch School of Medicine researchers are reporting a possible new blood test to help diagnose heart attacks.

21 Sep 2011

Loyola offers 15 minute emergency balloon angioplasty for heart attack patients

When 45-year-old Bobbie Jeske arrived at Loyola's ER with a massive, life-threatening heart attack, it took Dr. Fred Leya just 15 minutes to perform an emergency balloon angioplasty.

21 Sep 2011

New floating microscopic device for researchers to study wide range of cellular processes

It's a bit of a challenge. But, imagine a microscopic jet vacuum cleaner, the size of a pen nib that hovers over cell surfaces without ever touching them. Then imagine that the soap in the cleaning solution is replaced with various molecules that can be selectively delivered to the cells. This gives you a sense of a new device that researchers believe will serve as a powerful tool to study the behaviour of living cells and a range of crucial cellular processes, from cancer cell formation to how neurons align themselves in the developing brain.

21 Sep 2011

NIH to honor two Scripps Research scientists with innovator awards

Two Scripps Research Institute scientists have won prestigious National Institutes of Health (NIH) Director's New Innovator Awards. The recipients are Assistant Professor Michael Petrascheck of the institute's La Jolla, California campus, and Assistant Professor Brian Paegel of the Jupiter, Florida campus.

21 Sep 2011

FSS initiates FlexStent clinical trial for treatment of peripheral arterial disease

Flexible Stenting Solutions Inc. announced today the successful treatment of the first two patients enrolled in the OPEN (Evaluation of Safety and Efficacy of the FlexStent FemorOPopliteal Self-Expanding StENt System) clinical trial.

21 Sep 2011

FDA clears Anulex's fiXate Tissue Band System to treat chronic trunk/limb pain

Anulex Technologies, Inc., a privately held medical device manufacturer, has announced the U.S. Food and Drug Administration (FDA) clearance to market the fiXate Tissue Band product, designed to secure Spinal Cord Stimulation (SCS) lead anchors to the fascia or interspinous/supraspinous ligament in patients with chronic, intractable pain of the trunk and/or limbs.

21 Sep 2011

HIMSS Asia Pac’11 focuses on eHealth records

The HIMSS (Healthcare Information and Management Systems Society) Asia Pac ’11 Conference and Exhibition incorporating the HIMAA 2011 National Conference, opened on Tuesday, bringing together leading international experts in healthcare information systems and technology.

21 Sep 2011